FDA Approved: SUBLOCADE — Supplemental Application (Indivior Inc.)

View source ↗

Summary

FDA approved a supplemental application for SUBLOCADE (buprenorphine) filed by Indivior Inc., resulting in changes to the product labeling.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Opioid Use Disorder

Drugs mentioned

• SUBLOADE (buprenorphine)

Snippet

SUPPL AP for SUBLOCADE (BUPRENORPHINE)